Clin2
NCT07025980Possibly a fitNot yet recruiting

Probiotics for fatty liver disease

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertensionHyperlipidaemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
114 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have a diagnosis of fatty liver disease (MASLD), confirmed by ultrasound and a special liver scan.
  • You have metabolic syndrome, meaning you have extra belly fat plus at least two of these: high blood pressure, diabetes or high blood sugar, or abnormal cholesterol or triglycerides.
  • You are not pregnant.
  • You do not drink a lot of alcohol (more than about 2 drinks a day for men or 1 for women).
  • You have not taken antibiotics or probiotics in the last 3 months, and you are not on medications like steroids, methotrexate, or amiodarone.
  • You do not have other liver diseases (like hepatitis, autoimmune, or genetic conditions) or cirrhosis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease

This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.

New Taipei City
NCT06873165Recruiting
Gut bacteria treatment for fatty liver disease

This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.

Taipei
NCT06563921Not yet recruiting
Probiotic supplement for fatty liver disease

This study tests whether a probiotic supplement can improve liver health in people with fatty liver disease. It aims to see if probiotics reduce liver fat or inflammation, which could help manage the condition.

NCT06873412Not yet recruiting
Probiotic supplement for liver health and metabolism

This trial tests whether a probiotic supplement can improve liver health and metabolism in adults with early signs of fatty liver or related conditions. It may help reduce fat in the liver and improve blood sugar and blood pressure.

NCT06585982Recruiting
Synbiotics for MAFLD: gut health and liver fat study

This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.

Semarang, Semarang

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.